REQUEST A DEMO
Total
USD $0.00
Search more companies

Lexmark Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lexmark Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Lexmark Pharmaceuticals Private Limited is an enterprise located in India, with the main office in Mahesana. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on October 10, 2013. The company’s latest financial report indicates a net sales revenue drop of 7.65% in 2025. Its total assets grew by 9.31% over the same period. Lexmark Pharmaceuticals Private Limited’s net profit margin increased by 0.14% in 2025.

Legal Address
778, Paiki, At Post Karanpur, Taluka- Unjha, Dist.:Mahesana
Mahesana; Gujarat; Postal Code: 384170

Contact Details: Purchase the Lexmark Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Lexmark Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Lexmark Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
October 10, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Lexmark Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-7.65%
Total Operating Revenue
-7.65%
Operating Profit
115.39%
EBITDA
104.63%
Net Profit/Loss for the Period
32.48%
Total Assets
9.31%
Total Equity
15.97%
Operating Profit Margin
3.42%
Net Profit Margin
0.14%
Return on Equity (ROE)
1.72%
Debt / Equity
220%
Quick Ratio
1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?